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To the editorial board of Journal of Trauma  
 
We acknowledge the letter to the editor and the potential conflicts of interests of the authors.  
 
To avoid selection bias, the inclusion or exclusion of patients was carried out by an independent 
emergency department physician who included patients at the emergency department (please 
refer to page 42 of the trial protocol (1)). The ASA scores reported in the manuscript correspond 
to the scores as recorded by anesthesiologists at a later time point after the inclusion of study 
participants. Indeed, in some patients, the ASA score may have deteriorated after the study 
inclusion. Furthermore, the severity of comorbidities may have been estimated differently by 
physicians at study inclusion and anesthesiologists, leading to higher recorded ASA scores by the 
latter. Of note no patient rated as ASA 5 died within 30 days of the operation.  
 
We acknowledge that many surgical facilities may not be familiar with intra-abdominal 
placement of mesh and this lack of experience may be detrimental to outcome. However, at the 
Bern University Hospital, placement of intra-abdominal meshes is performed routinely in both 
emergency and elective procedures. The implantation of intra-abdominal mesh has not been 
shown to be associated with specific complications in previous studies published by our 
department (2-6)[1-5]. Furthermore, the described complications in patients following mesh 
placement, such as mesh dissolution, non-integration into the abdominal wall or late onset mesh 
infection are unlikely to be related to the surgical technique. 
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Our study was designed and powered for incisional hernia as its primary outcome. However, 
detection bias as described in the letter to the editor concerns a safety outcome and not the 
primary outcome parameter. We agree with the authors that the meshes should not affect 
anastomotic healing and patient deterioration. However, patients #3 and #10 both had severe 
mesh-associated complications such as torn mesh, necrosis or hematoma of the abdominal wall 
that are highly likely to become clinically apparent. In addition, case #12, had a type 2 surgical 
site infection according to CDC criteria (7)[6]. 
 
Based on the letter to the editor by Gachabayov and Latifi, we recalculated the p-value in 
question using SPSS and received the same result as reported in our publication. The 
corresponding SPSS output has been made available to the editorial board. 
 
This study has been designed to assess incisional herniation in an at risk patient cohort. 
However, the significantly higher rate of complications seen with the implantation of Strattice 
meshes did not allow the completion of the study and to reach the primary endpoint. Therefore 
this study is obviously underpowered to identify differences for the primary endpoint. However, 
the main statement of the publication is the description of safety related events, which were 
significantly different. Thus, we disagree with the authors of this letter that no robust conclusion 
can be drawn from this study. Based on the results of this study, the prophylactic use of biologic 
Strattice meshes cannot be recommended in patients undergoing emergency abdominal surgery 
because of safety concerns.  
Your Sincerely, 
Manuel Jakob, MD   Guido Beldi,MD 
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